Moore says MSIT med‑tech coverage bill has momentum but implementation questions remain

A caller who identified herself as an industry champion in Park City asked whether Moore's work on coverage for innovative medical technologies — an effort he referred to as MSIT — was likely to finish this year.

Moore said he has worked on the issue since coming to Congress, noted prior rulemaking under earlier administrations, and described MSIT as a bipartisan legislative effort that had committee progress and growing support. "We got it done. It's... quite bipartisan," he said, while acknowledging dissenting voices have been waning and some members who opposed it previously changed votes in favor.

At the same time, Moore said there were lingering implementation concerns within the administration and CMS about how to operationalize coverage for breakthrough technologies. He said he and industry stakeholders have been engaging CMS and other agencies to resolve practical questions and that the bill’s Senate status was unclear. Moore said his office would continue to track and provide updates on the measure.

The transcript records the representative’s description of legislative momentum and administrative hesitation; it does not include final Senate action or a timetable for implementation.